What's breaking now, across thousands of outlets.
The biosimilar to Johnson & Johnson's Stelara will be commercialised in nine additional markets, expanding Biocon's global reach in immunology
We haven't written up this one. Business Standard IN has the full story — the link below goes straight to it.
It is a week packed with central bank meetings and corporate earnings that will further test investor confidence.
Bitcoin slipped 0.97 per cent to US$79,912.85 over the last 24 hours. That number alone looks mild for an asset known for violent swings.
Other plantation stocks saw more muted movements.
Key PointsNvidia’s CFO said its revenue opportunity per gigawatt has grown from about $18 billion with Hopper to $25 billion with Blackwell and $40 billion with Vera Rubin.
Spot gold rose 0.4% to $4,009.87 per ounce by 0342 GMT, after hitting its lowest level since mid-July in the previous session
